Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meera Mahalingam

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Journal of Cutaneous Pathology|July 30, 2009
Anaplastic Kaposi's sarcoma: an uncommon histologic phenotype with an aggressive clinical courseYue Yu, Marie-France Demierre, Meera Mahalingam
The American Journal of Dermatopathology|November 22, 2014
Reading between the layers: early histopathological findings in exogenous ochronosisSandhya Chowdary, Meera Mahalingam, Neelam A Vashi
The American Journal of Dermatopathology|August 12, 2010
Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesisMeera Mahalingam, Anvita Srivastava, Mai P Hoang
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 17, 2010
Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepitheliomaOssama Abbas, Joanna E Richards, Meera Mahalingam
Advances in Anatomic Pathology|May 5, 2016
BRAF and Epithelial-Mesenchymal Transition: Lessons From Papillary Thyroid Carcinoma and Primary Cutaneous MelanomaBrendon Mitchell, Jagdish K Dhingra, Meera Mahalingam
Indian Journal of Dermatology, Venereology and Leprology|December 3, 2022
Diffuse large B-cell lymphoma of the skin and testis: A diagnostic and staging dilemmaKei Shing Oh, Shyam Prajapati, Meera Mahalingam
Melanoma Research|August 29, 2015
The HGF-cMET signaling pathway in conferring stromal-induced BRAF-inhibitor resistance in melanomaDan C Filitis, Jake Rauh, Meera Mahalingam
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 9, 2012
Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanomaJohn K Feller, Shi Yang, Meera Mahalingam
International Journal of Surgical Pathology|November 29, 2013
Histopathology of Keratoacanthoma Revisited: Utility of Orificial Size as a Diagnostic AdjunctPhyu P Aung, Leomar Y Ballester, Meera Mahalingam
The American Journal of Dermatopathology|March 10, 2020
SOX-10 and S100 Negative Desmoplastic Melanoma: Apropos a Diagnostically Challenging CaseSarah Kooper-Johnson, Meera Mahalingam, Daniel S Loo
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Journal of Cutaneous Pathology|July 30, 2009
Anaplastic Kaposi's sarcoma: an uncommon histologic phenotype with an aggressive clinical courseYue Yu, Marie-France Demierre, Meera Mahalingam
The American Journal of Dermatopathology|November 22, 2014
Reading between the layers: early histopathological findings in exogenous ochronosisSandhya Chowdary, Meera Mahalingam, Neelam A Vashi
The American Journal of Dermatopathology|August 12, 2010
Expression of stem-cell markers (cytokeratin 15 and nestin) in primary adnexal neoplasms-clues to etiopathogenesisMeera Mahalingam, Anvita Srivastava, Mai P Hoang
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 17, 2010
Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepitheliomaOssama Abbas, Joanna E Richards, Meera Mahalingam
Advances in Anatomic Pathology|May 5, 2016
BRAF and Epithelial-Mesenchymal Transition: Lessons From Papillary Thyroid Carcinoma and Primary Cutaneous MelanomaBrendon Mitchell, Jagdish K Dhingra, Meera Mahalingam
Indian Journal of Dermatology, Venereology and Leprology|December 3, 2022
Diffuse large B-cell lymphoma of the skin and testis: A diagnostic and staging dilemmaKei Shing Oh, Shyam Prajapati, Meera Mahalingam
Melanoma Research|August 29, 2015
The HGF-cMET signaling pathway in conferring stromal-induced BRAF-inhibitor resistance in melanomaDan C Filitis, Jake Rauh, Meera Mahalingam
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 9, 2012
Immunohistochemistry with a mutation-specific monoclonal antibody as a screening tool for the BRAFV600E mutational status in primary cutaneous malignant melanomaJohn K Feller, Shi Yang, Meera Mahalingam
International Journal of Surgical Pathology|November 29, 2013
Histopathology of Keratoacanthoma Revisited: Utility of Orificial Size as a Diagnostic AdjunctPhyu P Aung, Leomar Y Ballester, Meera Mahalingam
The American Journal of Dermatopathology|March 10, 2020
SOX-10 and S100 Negative Desmoplastic Melanoma: Apropos a Diagnostically Challenging CaseSarah Kooper-Johnson, Meera Mahalingam, Daniel S Loo
Pageof 14